Citadel Advisors
DRTX

Citadel Advisors’s DURATA THERAPEUTICS INC COM STK (DE) DRTX Stock Holding History

Citadel Advisors’s Portfolio DRTX Stock Details DRTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q4 		– Sell
-15,900
Closed -$202K – 9064
2014
Q3 		$202K Buy
15,900
+13,800
+657% +$206K ﹤0.01% 5720
2014
Q2 		$36K Buy
+2,100
New +$31.3K ﹤0.01% 6973

Citadel Advisors's DRTX Position: Q4 2014 in Review

Citadel Advisors sold out of DURATA THERAPEUTICS INC COM STK (DE) (DRTX) in Q4 2014, closing a stake of 20,951 shares — an estimated $266K sold.

Citadel Advisors first reported a position in DRTX in Q2 2014 and held it in 2 quarters. The position peaked at $266K in Q3 2014. 0 funds tracked by Wall St. Rank hold DRTX as of Q4 2014.

  • Citadel Advisors reported no remaining DURATA THERAPEUTICS INC COM STK (DE) position as of Q4 2014 after selling out during the quarter.
  • Citadel Advisors sold 20,951 DURATA THERAPEUTICS INC COM STK (DE) shares in Q4 2014, an estimated $266K.
  • Citadel Advisors first reported a position in DURATA THERAPEUTICS INC COM STK (DE) in Q2 2014 and held it in 2 quarters.
  • Citadel Advisors's DURATA THERAPEUTICS INC COM STK (DE) position peaked at $266K in Q3 2014.
  • 0 funds tracked by Wall St. Rank held DURATA THERAPEUTICS INC COM STK (DE) as of Q4 2014.

Based on Citadel Advisors's 13F filing for Q4 2014, filed 17 Feb 2015.